Life Science Update | July 2026
Changes to Mexican Patent Law May Impact Life Science Patent Prosecution Jason J. Jardine & Bailey R. Arenberg While recent amendments to Mexico’s patent laws promote faster prosecution and earlier decisions on...
Changes to Mexican Patent Law May Impact Life Science Patent Prosecution
Key Takeaway: While recent amendments to Mexico’s patent laws promote faster prosecution and earlier decisions on patents, concerns abound as to the feasibility and integrity of the prosecution process. On...
Life Science Update | March 2026
AI and Genomics: A New Era of Personalized Medicine Robert J. Hilton, Ph.D. & Bailey R. Arenberg Advances in AI and genomic analysis will allow medical providers to tailor treatment for...
AI and Genomics: A New Era of Personalized Medicine
Key Takeaway: Advances in AI and genomic analysis will allow medical providers to tailor treatment for individual patients at the genome level, but challenges exist for protecting AI-assisted inventions. Genomic...
Litigation Update | February 2026
Result-Oriented Claims and Section 101: Claiming the How Daniel Kiang & Brandon Cormier Result-oriented claims were found ineligible under 35 U.S.C ? 101 because the claims did not describe how...
Litigation Update | February 2026
Result-Oriented Claims and Section 101: Claiming the How Daniel Kiang & Brandon Cormier Result-oriented claims were found ineligible under 35 U.S.C ? 101 because the claims did not describe how...
Wireless TV Is So Main“stream”
GOTV STREAMING, LLC V. NETFLIX, INC. Before Prost, Clevenger, and Taranto. Appeal from the United States District Court for the Central District of California. Summary: A winning claim construction isn’t...
Life Science Update | October 2025
USPTO, JPO, and EPO Meet to Discuss Global IP Challenges Joseph Mallon, Ph.D. & Ashley C. Morales Beginning on October 20, 2025, recently confirmed United States Patent and Trademark Office (USPTO) Director...
AI and the Fight Against Antimicrobial Resistance
Antimicrobial resistance has become a major concern in recent years. According to studies, approximately 1.1 million deaths each year are linked to bacterial resistance to antimicrobial drugs.[1] The fear of...
Keeping PACE With CRISPR
AGILENT TECHNOLOGIES, INC. v. SYNTHEGO CORP. Before Prost, Linn, and Reyna. Appeal from the Patent Trial and Appeal Board. Summary: Obviousness does not require all claimed limitations to be expressly...
Executive Order 14297 and the Global Drug Market: Policy, Pricing, and Uncertainty
On May 12, 2025, President Trump issued Executive Order 14297[1] targeting prescription drug prices in America. The stated purpose of this order is to combat high drug prices in the...
Suspension of the Climate Change Mitigation Pilot Program: What Happens Now?
Effective January 28, 2025, the new administration suspended the Climate Change Mitigation Pilot Program (CCMPP) at the United States Patent and Trademark Office (USPTO).[1] The USPTO had instituted this program...
Renewed Efforts in Congress for Pharmaceutical Patent Reform
With the recent convocation of the 119th Congress, a change in administration, and resignation of USPTO Director Vidal, pharmaceutical patent reform is likely on the minds of many in Washington....
